Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Naldemedine in Clinical Practice in Cancer Patients With Opioid Induced Constipation: Clinical Outcomes and Patient Experience

NCT07231796 is registered in ClinicalTrials.gov with Professor Monique A. H. Steegers as lead sponsor.

NCT NCT07231796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07231796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Naldemedine in Clinical Practice in Cancer Patients With Opioid Induced Constipation: Clinical Outcomes and Patient Experience
Lead sponsor
Professor Monique A. H. Steegers
Phase
Observational
Overall status
Recruiting
Start date
January 2, 2026
Completion date
March 15, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, opioid induced constipation (oic)